163 related articles for article (PubMed ID: 36042597)
1. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
3. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
5. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
9. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.
Yang X; Cheng Y; Zhou J; Zhang L; Li X; Wang Z; Yin S; Zhai L; Huang T; Wu X; Shen B; Dong Y; Zhao L; Chi Y; Jia Y; Wang J; He Y; Dong X; Xiao H; Wang J
Adv Sci (Weinh); 2022 Mar; 9(8):e2104472. PubMed ID: 35064767
[TBL] [Abstract][Full Text] [Related]
11. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies.
Barczyński B; Frąszczak K; Kotarski J
J Drug Target; 2022 Apr; 30(4):359-367. PubMed ID: 34753372
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature.
Tseng CH
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356646
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.
Kyo S; Nakayama K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842547
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
19. Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
Sivalingam VN; Kitson S; McVey R; Roberts C; Pemberton P; Gilmour K; Ali S; Renehan AG; Kitchener HC; Crosbie EJ
Br J Cancer; 2016 Feb; 114(3):281-9. PubMed ID: 26794276
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis.
Gong H; Chen Y; Zhou D
Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
